Workflow
Bain Capital Specialty Finance(BCSF) - 2025 Q4 - Annual Report
2026-02-26 23:05
FORM 10-K F1, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 814-01175 BAIN CAPITAL SPECIALTY FINANCE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 81-2878769 (Sta ...
German American(GABC) - 2025 Q4 - Annual Report
2026-02-26 22:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Commission File Number 001-15877 GERMAN AMERICAN BANCORP, INC. (Exact name of registrant as specified in its charter) Indiana 35-1547518 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 711 Main Street, Box 810, Jasper, Indiana 47546 (Address of Prin ...
RingCentral(RNG) - 2025 Q4 - Annual Report
2026-02-26 22:48
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________________________________________________________________ FORM 10-K ______________________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number: ...
Emergent BioSolutions(EBS) - 2025 Q4 - Annual Report
2026-02-26 22:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33137 EMERGENT BIOSOLUTIONS INC. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 14-1902018 | | --- | --- | | (State or Oth ...
California Water Service(CWT) - 2025 Q4 - Annual Report
2026-02-26 22:39
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file No. 1-13883 CALIFORNIA WATER SERVICE GROUP (Exact name of registrant as ...
ServisFirst Bancshares(SFBS) - 2025 Q4 - Annual Report
2026-02-26 22:37
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______to_______ Commission file number 001-36452 SERVISFIRST BANCSHARES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 26-0734029 (State or ...
HealthStream(HSTM) - 2025 Q4 - Annual Report
2026-02-26 22:33
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-27701 HEALTHSTREAM, INC. (Exact name of registrant as specified in its charter) incorporation or organization) Tennessee 62-14 ...
SJW (SJW) - 2025 Q4 - Annual Report
2026-02-26 22:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-8966 H2O AMERICA (Exact name of registrant as specified in its charter) Delaware 77-0066628 (State or other jurisdiction of i ...
CME Group(CME) - 2025 Q4 - Annual Report
2026-02-26 22:30
Financial Position - The company has fixed-rate borrowings of $3.4 billion as of December 31, 2025, with no variable-rate borrowings [309]. - The company maintains a $7.0 billion multi-currency line of credit, with the option to increase it to $10.0 billion, to provide temporary liquidity in case of a clearing firm default [314]. - The company has a committed facility of up to $750.0 million for foreign currency conversions, subject to annual renewal [316]. - The clearing house has designated $150.0 million of corporate contributions to cover potential defaults by clearing firms [325]. Performance Bond and Risk Management - Aggregate performance bond deposits for clearing firms amounted to $347.3 billion, including cash performance bond deposits and letters of credit [317]. - The company has established performance bond requirements to cover at least 99% of expected price changes for a given product within a historical period [311]. - The company has assessment powers that could require non-defaulting clearing firms to contribute up to 550% of their existing guaranty fund requirements in the event of multiple defaults [320]. - The company has policies in place to monitor financial requirements for clearing firms, but these may not prevent defaults [312]. - The company assesses non-defaulting clearing firms based on potential obligations from the failure of the third and fourth largest clearing firms [325]. Foreign Currency Transactions - Aggregate transaction losses for foreign currency transactions were $(6.0) million in 2025, $(3.0) million in 2024, and $(12.9) million in 2023, indicating fluctuations in foreign currency gains/losses [324]. - Aggregate translation gains (losses) for 2025, 2024, and 2023 were $163.2 million, $(61.0) million, and $70.8 million, respectively [326]. - The exposure to foreign currency risk related to performance bond deposits is considered minimal and not expected to materially impact financial condition or operating results [327]. Credit Risk - The company is exposed to significant credit risk from third parties, including clearing firms and their customers, which may default on obligations [310]. - BrokerTec Americas had a collateral balance of $200.0 million at the Fixed Income Clearing Corporation as of December 31, 2025 [321].
Goldman Sachs BDC(GSBD) - 2025 Q4 - Annual Report
2026-02-26 22:30
Investment Overview - The company has originated approximately $9.88 billion in aggregate principal amount of debt and equity investments from its formation in 2012 through December 31, 2025[403]. - As of December 31, 2025, the total investments amounted to $3,395.17 million, with a fair value of $3,261.72 million, compared to $3,673.58 million and $3,475.26 million as of December 31, 2024[419]. - The portfolio includes $3,088.32 million in first lien/senior secured debt, $138.15 million in first lien/last-out unitranche, and $50.61 million in second lien/senior secured debt as of December 31, 2025[419]. - The company focuses on lending to middle-market companies, defined as those with annual EBITDA between $5 million and $200 million[406]. - The company’s investment strategy involves leading negotiations and structuring loans, typically with maturities ranging from three to ten years and investment sizes from $10 million to $75 million or more[407]. Financial Performance - The company generates revenues primarily through interest income from investments, with additional income from various fees, including commitment and origination fees[412]. - As of December 31, 2025, the total portfolio weighted average yield at amortized cost was 9.3%, down from 10.1% in 2024, and at fair value it was 10.5%, down from 13.2% in 2024[421]. - The weighted average yield on debt and income-producing investments at amortized cost was 9.9% as of December 31, 2025, down from 11.2% in 2024[422]. - The median EBITDA of portfolio companies increased to $71.75 million in 2025 from $66.14 million in 2024[422]. - Total investment income decreased from $434.37 million in 2024 to $365.57 million in 2025, a decline of approximately 15.9%[435]. - Net investment income after taxes fell from $252.55 million in 2024 to $181.57 million in 2025, representing a decrease of about 28.1%[438]. - The net increase in net assets from operations was $119.27 million in 2025, compared to $62.87 million in 2024, indicating a significant improvement[435]. Investment Quality - As of December 31, 2025, 97.2% of total investments were performing, compared to 95.5% in 2024[431]. - The fair value of investments graded as Grade 2 decreased to $2,991.99 million (91.7% of total) in 2025 from $3,238.74 million (93.2% of total) in 2024[428]. - The increase in Grade 3 investments was primarily due to $98.72 million being downgraded from Grade 2 due to financial underperformance[430]. - The weighted average interest coverage improved to 2.0x in 2025 from 1.8x in 2024[422]. Leverage and Debt Management - The company’s leverage strategy includes a senior secured revolving credit agreement and various notes, allowing it to borrow money to increase yield, subject to an asset coverage ratio of at least 150%[417]. - The asset coverage ratio was 175%, down from 181% in 2024, indicating a slight decrease in financial leverage[447]. - The company has $505.00 million borrowed under the Revolving Credit Facility to fully repay the 2026 Notes on January 15, 2026[480]. - The 2025 Notes, amounting to $360.00 million, were fully repaid on February 10, 2025, using proceeds from the Revolving Credit Facility[464]. - The company issued $400.00 million of 6.375% unsecured notes due 2027, with interest payable semi-annually starting September 11, 2024[467]. Risk Management - The company may originate "covenant-lite" loans, which have fewer financial maintenance covenants, potentially increasing risk in case of borrower default[405]. - The company expects net investment income to be affected by the difference between the rates at which it invests and borrows, indicating sensitivity to interest rate changes[486]. - Interest rate sensitivity analysis shows that a 300 basis point increase in interest rates could result in a net income increase of $41.49 million, while a 300 basis point decrease could lead to a net income decrease of $34.60 million[489]. - The company regularly measures its exposure to interest rate risk and manages it by comparing interest rate sensitive assets to liabilities[488]. - The company has entered into interest rate swaps to mitigate the impact of changes in market interest rates on its net asset value[487]. Shareholder Value - The company declared a quarterly base distribution of $0.32 per share, payable on or about April 28, 2026[483]. - The company has a stock repurchase program authorized for up to $75.00 million, aimed at repurchasing shares when trading below the NAV per share[454]. - The dividend reinvestment plan allows automatic reinvestment of cash distributions unless stockholders opt out, enhancing shareholder value[456]. Operational Changes - The Board of Directors reduced its size from seven to six directors effective February 25, 2026, due to a vacancy from a former director's retirement[484]. - The company plans to utilize existing and future funds primarily for investments in portfolio companies and general corporate purposes[448].